Your browser doesn't support javascript.
loading
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?
Gafar, F; Alffenaar, J-W C.
Afiliación
  • Gafar F; Unit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands, Division of Pharmacology and Therapy, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, McGill International TB Centre
  • Alffenaar JC; Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW, Australia, School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia.
Int J Tuberc Lung Dis ; 27(5): 345-347, 2023 05 01.
Article en En | MEDLINE | ID: mdl-37143226
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Isoniazida / Antituberculosos Límite: Child / Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Isoniazida / Antituberculosos Límite: Child / Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2023 Tipo del documento: Article